# NCT00098475 (NCT00098475)

> Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00098475
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: National Cancer Institute (NCI)
- Conditions: DS Stage I Multiple Myeloma; DS Stage II Multiple Myeloma; DS Stage III Multiple Myeloma
- Interventions: Dexamethasone; Laboratory Biomarker Analysis; Lenalidomide; Thalidomide
- Enrollment: 452
- Primary outcome: Proportion of Patients With Objective Response (First Phase, Step 1)

## Commentary we found

- X threads: 71

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct00098475

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00098475", "email": "<work email>"}; the inbox owner confirms by the emailed link.